Tagged stem-cells
Press Release
A Revolutionary Breakthrough in Biomedical Testing: AmeboGenesis Introduces Sustainable Amebocyte Production for LAL Testing to Detect Bacterial Contamination
Limulus Amebocyte Lysate (LAL) Can Now Be Produced Without Harvesting the Blood of ~800,000 Horseshoe Crabs Each Year, Which Will Help Restore Their Natural Population Read More
Press Release
Bioreactor Market Revenue to Cross USD 16 Bn by 2027: Global Market Insights Inc.
Single-use bioreactors market is estimated to attain a CAGR of 20.2% through 2027 owing to various advantages such as reduced cross contamination, cost-effectiveness, flexibility and increased productivity. Read More
Press Release
Longeveron Announces Japanese Approval of Clinical Trial for Treatment of Aging Frailty With Longeveron's Stem Cells
The Phase 2 study will assess the safety and efficacy of Longeveron's stem cell treatment under Japan's accelerated regulatory pathway for regenerative medicine. Read More
Press Release
Dr. A.J. Farshchian, Spokesperson for AASCP, Recommends FDA Safety Panel Discussion This Weekend
AASCP is hosting an FDA Panel and many distinguished physicians this weekend at their annual Scientific Congress. All physicians practicing stem cell treatments should not miss this event on Nov. 1-3, 2019. Read More
Press Release
American Academy of Stem Cell Physicians Announced Today That Their Safety Panel Session is Open and Free to the Public
Safety Panel Discussion to be held at 3:00 p.m. on Nov. 2, 2019, moderated by Ms. Janet Marchbrody. Highly anticipated session will discuss the growing safety concerns of the industry. Read More
Press Release
New Drug Screening Tool for Cancer Research Comes to Market
Breakthrough bioengineered, decellularized Wharton's Jelly matrix platform facilitates precision in vitro targeting of cancer stem cells (CSCs). The Sanatela™ Matrix is a revolutionary, natural 3-D biomaterial that gives researchers a tool to cultivate and study stem cells, including cancer stem cells. This matrix tissue opens new research opportunities for the development of individualized cancer treatments in the lab and for High-Throughput Drug Screening applications by pharmaceutical and biotechnology companies. Read More
Press Release
Dr. Steven Victor, CEO, Medical Director of ReGen Medical, is a Co-Author of Article Published in Journal of Regenerative Medicine Vol:8 1 2019
Dr. Steven Victor Co-Author of "Stem Cells and Regenerative Therapies: Clarification of Terminology and Potential Applications in Aging and Neurodegenerative Disorders" Read More
Press Release
Dr. Steven Victor, CEO, Medical Director of ReGen Medical Has the Honor of Meeting HE Humaid Al Qutami, Director General of the DHA and Dr. Marwan Al Mulla, CEO of Health Regulation Sector at the 13th International Conference on Medical Regulation
13th International Conference on Medical Regulation (IAMRA) in Association with the Dubai Health Regulation Conference 2018 Read More
Press Release
